McKesson Operating Cash Flow decreased by 127.4% to -$918.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.5%, from -$1.38B to -$918.00M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 11.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.62B | $1.79B | $1.67B | $2.60B | -$941.00M | $854.00M | $254.00M | $4.99B | -$1.05B | $1.77B | -$2.38B | $5.98B | -$1.38B | $2.88B | $1.23B | $3.35B | -$918.00M |
| QoQ Change | — | +210.2% | -6.7% | +55.9% | -136.2% | +190.8% | -70.3% | >999% | -121.1% | +268.4% | -234.5% | +350.8% | -123.1% | +308.8% | -57.3% | +172.0% | -127.4% |
| YoY Change | — | — | — | — | +42.0% | -52.2% | -84.8% | +92.0% | -11.8% | +107.5% | <-999% | +19.7% | -31.2% | +62.6% | +151.7% | -43.9% | +33.5% |